» Articles » PMID: 38737125

Predict LncRNA-drug Associations Based on Graph Neural Network

Overview
Journal Front Genet
Date 2024 May 13
PMID 38737125
Authors
Affiliations
Soon will be listed here.
Abstract

LncRNAs are an essential type of non-coding RNAs, which have been reported to be involved in various human pathological conditions. Increasing evidence suggests that drugs can regulate lncRNAs expression, which makes it possible to develop lncRNAs as therapeutic targets. Thus, developing methods to predict lncRNA-drug associations (LDAs) is a critical step for developing lncRNA-based therapies. In this study, we predict LDAs by using graph convolutional networks (GCN) and graph attention networks (GAT) based on lncRNA and drug similarity networks. Results show that our proposed method achieves good performance (average AUCs > 0.92) on five datasets. In addition, case studies and KEGG functional enrichment analysis further prove that the model can effectively identify novel LDAs. On the whole, this study provides a deep learning-based framework for predicting novel LDAs, which will accelerate the lncRNA-targeted drug development process.

Citing Articles

MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters.

Lu X, Jin H Front Pharmacol. 2024; 15:1486783.

PMID: 39679367 PMC: 11638538. DOI: 10.3389/fphar.2024.1486783.


Exploring heterocyclic scaffolds in carbonic anhydrase inhibition: a decade of structural and therapeutic insights.

Naeem N, Sadiq A, Othman G, Yassin H, Mughal E RSC Adv. 2024; 14(48):35769-35970.

PMID: 39534850 PMC: 11555472. DOI: 10.1039/d4ra06290f.


Detection and isolation of brain tumors in cancer patients using neural network techniques in MRI images.

Mir M, Madhi Z, Hamid AbdulHussein A, Khodayer Hassan Al Dulaimi M, Suliman M, Alkhayyat A Sci Rep. 2024; 14(1):23341.

PMID: 39375429 PMC: 11458613. DOI: 10.1038/s41598-024-68567-5.


Green synthesis and cytotoxic activity of functionalized naphthyridine.

Soleimani-Amiri S, Hojjati M, Hossaini Z Mol Divers. 2024; 29(2):1493-1506.

PMID: 39117889 DOI: 10.1007/s11030-024-10929-2.


Boosting antitumor efficacy using docetaxel-loaded nanoplatforms: from cancer therapy to regenerative medicine approaches.

Beheshtizadeh N, Amiri Z, Tabatabaei S, Seraji A, Gharibshahian M, Nadi A J Transl Med. 2024; 22(1):520.

PMID: 38816723 PMC: 11137998. DOI: 10.1186/s12967-024-05347-9.

References
1.
Liu J, Zhao Y, Chen L, Li R, Ning Y, Zhu X . Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR‑223/GLUT4 and SNHG20/miR‑4486/GLUT4 signaling. Mol Med Rep. 2022; 26(1). PMC: 9175273. DOI: 10.3892/mmr.2022.12734. View

2.
Tan W, Allred J, Moreno-Aspitia A, Northfelt D, Ingle J, Goetz M . Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients. Clin Breast Cancer. 2016; 16(2):82-6. PMC: 5567753. DOI: 10.1016/j.clbc.2015.11.003. View

3.
Chen X, Guan N, Sun Y, Li J, Qu J . MicroRNA-small molecule association identification: from experimental results to computational models. Brief Bioinform. 2018; 21(1):47-61. DOI: 10.1093/bib/bby098. View

4.
Winkle M, El-Daly S, Fabbri M, Calin G . Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021; 20(8):629-651. PMC: 8212082. DOI: 10.1038/s41573-021-00219-z. View

5.
Laarhoven T, Nabuurs S, Marchiori E . Gaussian interaction profile kernels for predicting drug-target interaction. Bioinformatics. 2011; 27(21):3036-43. DOI: 10.1093/bioinformatics/btr500. View